Skip to content

Side by side

GHRP-6 vs IGF-1 LR3

Both are discussed for muscle & performance. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.

GHRP-6 and IGF-1 LR3 compared on what BioAlmanac records.
 GHRP-6IGF-1 LR3
What it isThe oldest of the growth hormone releasing peptides, and the one with the strongest effect on hunger. That appetite stimulation is the defining fact about it.A modified insulin-like growth factor engineered to last far longer in the body than the natural hormone. It can cause hypoglycaemia, which makes it the most acutely dangerous compound on this site.
EvidenceHow much human evidence exists, not how well it works.Early human trialsPreclinical
Regulatory statusReviewed 2026-08-16Not approved for human use in any jurisdiction. Studied in humans in early-phase research decades ago; development was not carried through to approval. Sold only as a research chemical.Not approved for human use in any jurisdiction, and never studied in a human trial. Recombinant IGF-1 itself (mecasermin) is approved for severe primary IGF-1 deficiency, and its labelling carries an explicit hypoglycaemia warning. That warning is the closest thing to clinical safety information this class has.
RoutesSubcutaneousSubcutaneous, Intramuscular
Half-life0.35 hours24 hours
Cheapest per mgVials only, read from vendors' own listings and dated on the price index.$1.60/mg$32.50/mg
Median per mg$4.10/mg$79.00/mg
Vendors with a price1832
Storage once mixedRefrigerated at 2–8 °C. Do not freeze once mixed.Refrigerated at 2–8 °C. Do not freeze once mixed. Larger proteins are less forgiving of temperature swings than short peptides.

Compare two other compounds · The full price index

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.